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Bing Liang1, Dejuan Kong1, Yang Liu1, Nan Liang1, Mengzi He1, Shumei Ma1* and Xiaodong Liu2*Abstract
Purpose: Autophagy has attracted attentions as a novel mechanism for tumor development. In this study Human
ovarian carcinoma cell line SKOV3 and multidrug-resistant phenotype SKVCR cells were used and the roles of
autophagy in radiation-induced cell death were analyzed.
Methods and materials: Cell viability was examined by colony formation and cell counting kit-8 (CCK-8) assay,
3MA and ZVAD were used to block autophagy and apoptosis, respectively. Quantitative real-time PCR was used to
detect mRNA level and Western blot was used to detect protein expression, monodansylcadaverine (MDC) staining
and flow cytometery were used for autophagy, apoptosis and cell cycle dynamics, respectively.
Results: (1) The radiosensitivity exhibited differently in SKOV3 and SKVCR cells (SKOV3: D0=3.37, SKVCR: D0= 4.18);
compared with SKOV3 the constitutive expression of MAPLC3 in SKVCR was higher, but no change of Caspase-3 and
cleaved Caspase-3. (2) The ionizing radiation (IR)- induced apoptosis and autophagy were significant in both cells (P<0.05);
inhibition of apoptosis with ZVAD showed no impact on survival of SKOV3 and SKVCR cells after radiation, while
inhibition of autophagy significantly decreased viability in SKVCR cells, for SKVO3 cells only low level of radiation (2 Gy
and 4 Gy) could decrease the viability(P<0.05). (3) ZVAD inhibited apoptosis and autophagy in both cells, 3MA inhibit
apoptosis in SKOV3, and promote apoptosis in SKVCR, together with inhibition of autophagy. (4) G2/M arrest was induced
by radiation in both cells; the accumulation of G2/M was more significant in SKOV3, 3MA attenuated the
radiation-induced S phase delay in SKVCR.
Conclusion: IR-induced autophagy provides a self-protective mechanism against radiotherapy in SKVCR cells, the use of
autophagy inhibitor, 3MA, increases the killing effects of radiation by inhibiting autophagy and radiation- induced S phase
delay, also by the increase of apoptosis, which suggests a better therapeutic strategy in drug- resistant SKVCR ovarian
cancer cells.
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Epithelial ovarian cancer(EOC)is the most lethal Gynecolo-
gic malignancy, with 21,990 estimated new cases and 15,
460 deaths in USA in 2011[1]. Platinum/paclitaxel-based
chemotherapy is the current standard of treatment after
surgical staging and resection of abdominal and pelvic can-
cers. Despite the advances in chemotherapy, the prognosis* Correspondence: shmm2001@yahoo.com.cn; liuxd2002@126.com
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reproduction in any medium, provided the orstill remains poor since many patients develop abdominal
or pelvic recurrence that is resistant to further chemother-
apy. Radiotherapy has been shown to produce a response
in chemo-resistant ovarian cancers, and may offer the pos-
sibility of improved tumor control[2].
Tumor cells have the capacity to respond to chemo-
therapy and radiation through multiple growth arrest
and cell death pathways [3-5]. Various modes of cell
death have been known, such as necrosis, apoptosis and
autophagic cell death [6-8].
Apoptosis, the type I programmed cell death, has been
widely investigated under different circumstance includ-
ing radiotherapy and the one of the most importanttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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However, apoptosis is not the predominant form of cell
death as we have predicted, accounting for only 20% of
cases[9]. While, autophagy, the type II programmed cell
death, has been recently reported to play roles in the de-
velopment of cancer. Autophagy is an evolutionarily
conserved catabolic process for the degradation and re-
cycling of cytosolic, long-lived, or aggregated proteins,
and excess or defective organelles, and is primarily a re-
sponse to the stress of irradiation [10], chemotherapeutic
agents [7], starvation [11,12], growth factors withdrawal
[13], hypoxia or viral infection [14-17]. Dual roles of
autophagy have been reported, promotion of cell survival
or leading to cell death [18,19]. Therefore, autophagy is
considered to be a double-edged sword in the process of
tumor development. Elucidation of autophagy roles in
treatment responsiveness at different stages of cancer
progression is a complex and challenging task. Better
understanding of autophagy regulation and its impact on
treatment outcomes will potentially provide novel thera-
peutic targets in cancer.
In this study, the human ovarian cancer cell line
SKOV3 and multidrug-resistant phenotype SKVCR cells
were used and the killing effect of different radiation for-
mulae was assessed, the inhibitors of autophagy and
apoptosis were used to explore the synergetic effect and
the potential mechanism. These results will contribute
to improve the treatment efficacy for radiation-resistant
MDR phenotype ovarian cancer and bring new insights
for cancer development.Materials and methods
Cell culture
Human ovarian carcinoma cell lines SKOV3 and
multidrug-resistant phenotype SKVCR cells were ob-
tained from British Columbia Cancer Research Centre,
Vancouver, BC, Canada. Cells were maintained in
α-MEM with 10% fetal bovine serum and 100 U/ml of
penicillin/streptomycin, at 37°C in humidified atmos-
phere containing 5% CO2. SKVCR cells were cultured in
α-MEM medium containing 2.0μg/ml vincristine (VCR),
to maintain the drug-resistant phenotype.Irradiation and chemicals
Different radiation formulae were introduced as follows:
(A) 0Gy: no treatment was given; (B) 2Gy×5: 2 Gy in
every day for 5 times; (C) 1Gy ×2 ×5: 2 Gy (1 Gy 2 times
a day, 4 h interval) in every day for 5 times; (D) 10Gy×1:
10 Gy for 1 time. ZVAD (20μM, Enzo, USA) and 3MA
(2.5 mM or 5 mM Sigma-Aldrich Inc, USA) were used
as inhibitor of apoptosis and autophagy, respectively.
These agents were administered into cells 2 h before ra-
diation.X-ray irradiation was performed by using 180-KVp X-ray generator (Model XSZ-Z20/20, China) at a
dose rate of 0.40Gy/min.
CCK-8 assay
Radiosensitivity of SKOV3 and SKVCR was assayed by
using a Cell Counting kit-8 (CCK-8, Dojin Laboratories,
Kumamoto, Japan). 1×104 cells/well were seeded in 96-
well plates containing complete medium and incubated
for 24 h followed by different doses of ionizing radiation
for 48h. 10 μl of the CCK-8 solution was added to each
well and went on with incubation for 2 h in incubator.
The absorbance was measured at 450 nm using a micro-
plate reader (Synergy HT, Bio-Tek, USA).
Colony formation assay
After the treatment of radiation, cells were plated into
60mm petri dishes using standard culture media. Two
weeks later, cells were fixed with 4% formaldehyde,
stained with crystal violet and colonies containing more
that 50 cells were counted and normalized to their cor-
responding non-irradiated control. The surviving frac-
tion for a given treatment was calculated as the plating
efficiency of the irradiated samples relative to that of the
sham-irradiated ones. For each dose level in four groups,
three independent experiments were done. Multi-target
click model of GraphPad Prism 5.0 (Systat Software,
USA) was used to fit cell survival curves. The dose qua-
sithreshold (Dq) and mean lethal dose (D0) were
calculated.
Quantitative real-time PCR
Total RNA was isolated using RNAiso Plus (Takara Co.
Japan) according to the manufactures’ instructions.
Quality and quantity of RNA was analyzed by measuring
the A260/A280 ratio with ultraviolet spectrophotometry.
Reverse transcription was performed with 2 μg of total
RNA using PrimeScript Rtreagent Kit (Takara Co,
Japan). Then each sample was analyzed by quantitative
real-time PCR (qPCR) (Stratagene MX3000P, Japan) in
the SYBR Premix Ex TapII (Takara Co, Japan),setting the
cycles as follows:10s/95°C PCR initial activation step; 40
cycles of denaturation for 20 s/95°C and annealing step
for 20 s/60°C. The change in mRNA levels was deter-
mined by the formula 2−(ΔΔCT), where ΔCT is the
value from the threshold cycle (CT) of the treated sam-
ple subtracted from the CT value of untreated or zero
time-point control sample. The relative amount of
mRNA in the sample was normalized to GAPDH
mRNA. The primers for genes were as follows: MAPL-
C3II forward: 50-CCTAGAA GGCGCTTACAGCT-30 and
reverse 50-GGGACAATTTCATCCCGAAC-30; Caspase 3
forward: 50-TTCAGGCCTGCCGTGGTACA −3 and re-
verse: 50-CCAAGAATAATA ACCAGGTGCT-3;GAPDH
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reverse 50- TGGTGA AGA CG CCAGTGGA-30.
Western blot analysis
After the indicated treatment, 40 μg of total protein was
separated by SDS-PAGE, using a gradient gel [(10–12%),
Bio-Rad Laboratories], transferred to nitrocellulose mem-
brane, and analyzed by immunoblotting using the che-
miluminescence (Santa Cruz, CA, USA). The primary
antibodies used were Caspase 3 (Cell Signaling, Beverly,
MA, USA,1:500), MAPLC3 (Cell Signaling, Beverly, MA,
USA,1:500) or GAPDH (Santa Cruz, CA, USA,1:1000),
peroxidase-conjugated anti-mouse IgG or peroxidase-
conjugated anti-rabbit IgG. (Santa Cruz, CA, USA, 1:1000).Figure 1 The radiosensitivity in Human ovarian carcinoma cell lines S
formation assay was used to detect the survival curve, and Multi-target clic
cell survival curves. SKOV3: D0= 3.37,Dq=0.60, n=1.508; SKVCR: D0= 4.18, Dq
radiation formulae (0Gy,1Gy×2×5,2Gy×5,10Gy×1), cell viability was analyzed
SKVCR cells by CCK-8 assay. (D) SKOV3 and SKVCR cells were exposed to di
was analyzed by CCK-8 assay. *P<0.05, vs sham-irradiated.The intensity of protein bands were quantified using
image j software and the ratio of specific band to control
was analyzed.
MDC assay for visualization of autophagic vacuoles
Cells were seeded on cover slips over night followed by
treatment with different doses of radiation, 48h later
autophagic vacuoles were labeled with monodansylcada-
verine (MDC) by incubating cells with 50 μM MDC in
α-MEM at 37°C for 1 h. After incubation, cells were
washed with PBS and fixed with a solution of 4% paraf-
ormaldehyde for 20 min. Autophagic vacuoles were
examined using a fluorescence microscopy (Olympus,
XSZ-D2).KOV3 and multidrug-resistant phenotype SKVCR cells. (A) Colony
k model of GraphPad Prism 5.0 (Systat Software, USA) was used to fit
=1.05, n=1.78. (B) SKOV3 and SKVCR cells were exposed to different
by the Colony formation assay. (C) Dose-effects analysis in SKOV3 and
fferent radiation formulae (0Gy,1Gy×2×5, 2Gy×5, 10Gy×1 ), cell viability
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Cells were collected 24 h after radiation and 5 × 105
of cells were used for each sample. For cell cycle dis-
tribution analysis, cells were stained with RNase -con-
taining PI (propidium iodide) solution. For apoptosis
detection, cells were stained with PI and FITC labeled
Annexin-V. Stained cells were detected by Flow Cyto-
metry (BD Biosystems, USA) and data were analyzed
with CellQuest (BD Biosciences) and FlowJo softwares
(Tree Star Inc.).
Statistical analysis
All experiments were performed thrice and the data
were expressed as means ± SD. The difference be-
tween two mean values was evaluated by using the
Student’s t -test and considered to be statistically sig-
nificant when P < 0.05.
Results
The radiosensitivity in human ovarian carcinoma SKOV3
and multidrug-resistant phenotype SKVCR cells
SKOV3 and SKVCR cells were exposed to various doses
of radiation (0, 2, 4, 6 or 8 Gy), cell viability was mea-
sured by Colony formation and CCK8 assay. As shown
in Figure 1A and C, radiation decreased the cell viability
in SKOV3 and SKVCR, the D0, Dq and N values were
as follows: for SKOV3, D0= 3.37, Dq=0.60, n=1.508; for
SKVCR, D0= 4.18, Dq=1.05, n=1.78. SKOV3 andFigure 2 The endogenous expression of MAPLC3 and Caspase-3 in SK
level of MAPLC3. (B) Western blotting was used to detect the expression o
Caspase-3. (D) Western blotting was used to detect the expression of CaspSKVCR cells were than exposed to different radiation
formulae(0Gy, 1Gy×2×5, 2Gy×5,10Gy×1)and cell viabil-
ity was analyzed by the Colony formation and CCK8
assay. As shown in Figure 1B and D, radiation decreased
the cell viability in SKOV3 and SKVCR, there was no
difference among different radiation treatment. These
results showed that SKOV3 and SKVCR cells exhibited
differences in terms of radiosensitivity, radiation sup-
pressed the survival fraction more significantly in
SKOV3 than in SKVCR (P < 0.05).The endogenous expression of MAPLC3 and Caspase-3 in
SKOV3 and SKVCR cells
After we found a variation in the radiosensitivity be-
tween the two cell lines, we sought to find the contri-
butions of apoptosis and autophagy to the total cell
death. The basal autophagic and apoptotic levels were
measured, Figure 2 shown the expression level of
MAPLC3 II and Caspase-3 at the mRNA and protein
level which correlates with the autophagosome forma-
tion and apoptosis, respectively, the higher constitutive
expression of MAPLC3 II was detected in SKVCR by
real-time PCR (RT-PCR) and Western blot compared
with SKOV3 cells. However, we did not find significant
difference in the mRNA and protein level of both
Caspase-3 and cleaved Caspase-3 (marker of apoptosis)
between the two cell lines (Figure 2C and D).OV3 and SKVCR. (A) Real-time RT-PCR was used to detect the mRNA
f MAPLC3. (C) Real-time RT-PCR was used to detect mRNA level of
ase-3. GAPDH was used as internal control.
Figure 3 (See legend on next page.)
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Figure 3 The changes in apoptosis and autophagy after the treatment of irradiation in SKOV3 and SKVCR. (A,C) Flow cytometry was use
to quantitative the apoptotic rate in SKOV3 and SKVCR. (B,D) Statistical analysis of apoptotic rate. Results were expressed as the percentage of
untreated cells, Mean ± SD of thrice. *P<0.05, vs sham-irradiated. (F,H) MDC staining was used to detect the morphologic changes of autophagy
in SKOV3 and SKVCR. (G,I) Statistical analysis of autophagic rate based on MDC staining, Mean ± SD of ten vision fields. *P<0.05, vs sham-
irradiated. (J) Western blot was used to detect MAPLC3, the increase of MAPLC3II suggested the autophagy occurrence.
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both ovarian cancer cells
To understand the underlying mechanism of radiation-
induced cytotoxicity in SKOV3 and SKVCR cells, we
managed to explore the roles of apoptosis and autop-
hagy after radiation. Flow cytometric analysis was used
to detect apoptosis and MDC stain and western blot
were used to detect autophagy. In SKOV3 cells the
basal apoptotic rate in sham-irradiated group (control)
was 4.6%, exposure of cells to the different therapeutic
regimens of IR significantly increased the apoptosis
(Figure 3A and B). Similar scenario was exhibited in
SKVCR cells (Figure 3C and D), exposure to the differ-
ent regimens of IR enhanced the autophagic activity
significantly in both cell lines as detected by MDC im-
munofluorescence and increased MAPLC3II/I ratio
(Figure 3F-J).
Enhancement of radiation-induced cytotoxicity by
blocking autophagy in SKVCR cells
The role of autophagy during cancer therapy is paradox-
ical and seems to be dependent on cell context. Thus,
3MA and ZVAD were used to block autophagy and
apoptosis respectively. SKOV3 and SKVCR cells were
exposed to different dose of radiation (0 Gy,2 Gy,4 Gy,6
Gy,8 Gy) or different radiation formulae (0 Gy,1 Gy×2×5,2
Gy×5,10 Gy×1) with or without 3MA (2.5 mM or 5 mM)
and ZVAD(20 μM), cell viability was analyzed by CCK-8
assay. As shown in (Figure 4), inhibition of autophagy
significantly reduced the cell viability of both cell lines.
Importantly, In SKVCR cells, 3MA significantly
improved the IR-induced cytotoxicity. In SKOV3 cells
the IR- induced cell death was significantly increased by
3MA in 2 Gy and 4 Gy groups (P <0.05). The IR-
induced cell death was significantly increased by 3MA
in SKVCR cells (P<0.05), but no change in SKOV3 cells
(P>0.05). These findings indicate that autophagy plays a
predominant pro-survival role in MDR-ovarian cancer
cells, SKVCR.
Transaction between autophagy and apoptosis in ovarian
cancer cells
Next we wanted to simply delineate the underlying
mechanism behind the enhanced radiosensitivity upon
inhibition of autophagy. Therefore, 3MA and ZVAD
were used to block autophagy and apoptosis respectively.Flow cytometry analysis was used to detect apoptosis,
MDC stain and western blot were used to detect autop-
hagy Pre-treatment of SKOV3 and SKVCR with ZVAD
before exposure to IR markedly reduced the IR stimula-
tory effect on apoptosis. Pre-culture of SKOV3 cells with
3MA, significantly attenuated the IR-induced apoptosis.
Importantly, in SKVCR, the apoptotic rate showed sig-
nificant elevation upon pre-treatment with 3MA in irra-
diated and non-irradiated cells. We also found the
increase of cleaved caspase-3(apoptosis marker) in
SKVCR cells, wherein autophagy inhibition increased
the expression of cleaved caspase-3 before and after ra-
diation exposure (Figure 5A-E). Blocking autophagy with
3MA in SKVO3 and SKVCR significantly reduced the
number of cells undergoing autophagy as estimated by
MDC staining. Importantly, pre-culture of both cell lines
with ZVAD attenuated the IR-induced autophagic re-
sponse (Figure 5F-I). These findings indicate the pres-
ence of crosstalk between apoptosis and autophagy.
More importantly, the enhanced radiosensitivity in
SKVCR cells upon suppressing autophagy could be due
to concomitant up-regulation of apoptosis.
Autophagy inhibition alters the IR-induced cell cycle
arrest in SKVO3 and SKVCR cells
Finally, we sought to explore whether autophagy changes
was associated with cell cycle regulation. Hence, flow
cytometry analysis was performed pre- and post-IR in
the presence or absence of 3MA. In SKOV3 cells, radi-
ation decreased the cell number in G1/S phase signifi-
cantly and induced accumulation of cells at G2/M
phase. Inhibition of autophagy in SKOV3 cells with
3MA for 24 hours prior to irradiation caused borderline
ascend in G1/S phase, while G2/M phase also decreased
significantly (2.5 fold), compared with IR alone group
(Figure 6A-D). In SKVCR cells, radiation decreased the
cell number in G1/S phase significantly and induced ac-
cumulation of cells at G2/M phase, but S phase delay
was also observed. When the cells were pretreated
with 3MA, the cell number in G1/S phase increased
slightly, while S phase showed significant reduction after
radiation as compared with radiation alone group
(Figure 6E-H). These results suggest that attenuation of
the IR-induced S phase delay by 3MA could be also one
contributory factor in the enhanced radiosensitivity upon
autophagy inhibition.
Figure 4 Effects of inhibitors for autophagy and apoptosis on the cell survival rate. (A) Dose-effect changes after radiation in SKVO3 cells
with or without 3MA(2.5mM) and ZVAD(20μM). (B) Dose-effect changes after radiation in SKVCR cells with or without 3MA(2.5mM) and ZVAD
(20μM). (C) SKOV3 cells were exposed to different radiation formulae (0Gy,1Gy×2×5,2Gy×5,10Gy×1) with or without 3MA (5mM) and ZVAD(20μM),
cell viability was analyzed by CCK-8 assay. (D) SKVCR cells were exposed to different radiation formulae (0Gy,1Gy×2×5,2Gy×5,10Gy×1) cells with or
without 3MA (5mM) and ZVAD(20μM), cell viability was analyzed by CCK-8 assay. *P<0.05, vs sham-irradiated. Results were expressed as the
percentage of untreated cells, Mean ± SD of thrice. *P<0.05, vs untreated cell.
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Ovarian cancer is one of the most common genital
malignant tumors for female, maximal cytoreductive
surgery together with platinum-based chemotherapy
is the initial treatment program [20]. Drug resistance
is a major obstacle to successful treatment of ovarian
cancers [21]. Therefore, overcoming of drug-resistance
in ovarian cancer would become an important factor to
improve treatment efficacy. Radiotherapy functions as an
adjuvant therapy for the treatment of ovarian cancer
[22-24], mainly applies to the pre-operative and post-
operative adjuvant therapy or palliative treatment of
advanced ovarian cancer [25,26]. Radiotherapy has been
shown to produce a response in chemo-resistant ovariancancers, and may offer the possibility of improved tumor
control. Radiosensitivity of malignant ovarian tumors
varies markedly, dysgerminoma was classified as highly
radiosensitive, while ovarian endodermal sinus tumor,
emmature teratoma and embryonal carcinoma showed
the lowest radiosensitivity. Epithelial ovarian cancer
(EOC) and eranular cell carcinoma are moderately
radiosensitive.
To improve the efficacy of treatment of drug-resistant
ovarian cancer, the human epithelial ovarian cancer cell
line SKOV3 and multidrug-resistant(mdr) phenotype
SKVCR cells were exposed to different dose of radiation
(0 Gy, 2 Gy, 4 Gy, 6 Gy, 8 Gy) or different radiation for-
mulae (0 Gy, 1 Gy×2×5, 2 Gy×5, 10 Gy×1) with or
Figure 5 (See legend on next page.)
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Figure 5 The interrelationship between autophagy and apoptosis in SKOV3 and SKVCR. Apoptosis and autophagy were determined in the
presence or absence of 3MA or ZVAD, with or withour indicated IR regimens at 24 h. (A, C) Flow cytometry was used to quantitative the
apoptotic rate in SKOV3 and SKVCR. (B, D) Statistical analysis of apoptotic rate Results were expressed as the percentage of untreated cells, Mean
± SD of thrice. *P<0.05, vs untreated cells. (E) Western blot was used to detect caspase 3 and cleaved caspase 3 in SKVCR, the increase of cleaved
caspase 3 suggested the apoptosis occurrence. (F,H) MDC staining was used to detect the morphologic changes of autophagy in SKOV3 and SKVCR.
(G,I) Statistical analysis of autophagic rate, results were expressed as the percentage of untreated cells, Mean ± SD of thrice. *P<0.05, vs untreated cells.
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and ZVAD (apoptosis Inhibitor via caspase-3 regulation),
the changes of cell viability, apoptosis, autophagy and
cell cycle were analyzed in this study.
In order to know the radiosensitivity of ovarian can-
cers, cell viability was measured by colony formation
and CCK8 assay, radiation could induce cell death in
both cell lines and the mdr-phenotype SKVCR showed
more resistant than SKVO3. In general, the radiosensi-
tivity is proportional to the proliferation rate. One previ-
ous study found that SKOV3 and SKVCR showed
different cell doubling time, the doubling time in SKVCR
cells was prolonged approximately 1.8 times (53 hours
for SKVCR and 29 hours for SKOV3 cells) [27]. Zhang
et al. reported the mdr -transfected K-562 cells showed
resistance to radiation as compared with parental cells
[28], a similar trend was reported by Wei R et al. [29].
Together with our data, the fact that multi-drug resist-
ant cells are less radiosensitive as compared with paren-
tal cells has been further confirmed. How to treat this
kind of drug resistant and radiation-resistant cancer has
been the hot point.
Next we managed to find what’s the difference and the
underline mechanism which make SKVCR cells resistant
to chemotherapy, this will contribute to find more target
for treatment. It is well-known that apoptosis is import-
ant in determining the outcome of chemo- and
radiation- therapy [30,31] and can be triggered by antic-
ancer drugs and radiation. Besides, mounting evidence
suggest that cancer cells can commit to death by various
non-apoptotic pathways such as autophagy [32]. Then
we detected the constitutive expression of different types
of cell death and found that the basal level of autophagy
in SKVCR was significantly higher than in SKOV3 cells,
but for apoptosis there was no difference between
SKVCR and SKOV3 cells, suggesting autophagy might
associate with the MDR characteristics and play a pro-
survival role. Autophagy is a highly conserved cellular
process. It involves degradation of intracellular orga-
nelles and long-lived proteins to yield amino acids reuse
and energy recycle [33]. It was demonstrated in previous
researches that autophagy can have either pro-survival
or pro-death functions in an organism, depending on its
level of activation [34-37].
To make sure which type of cell death, autophagy or
apoptosis, would play predominant roles in killing effectof radiation, 3MA and ZVAD were used to block autop-
hagy and apoptosis respectively. Our result showed that
although these two cell lines were different in terms of
basal autophagy, ionizing radiation can induce both of
them to undergo apoptosis and autophagy (Figure 3). In-
hibition of apoptosis with ZVAD showed no impact on
survival of SKOV3 and SKVCR cell lines after radiation,
while inhibition of autophagy significantly decreased via-
bility in SKVCR cells, for SKVO3 cells only low level of
radiation (2 Gy and 4 Gy) could decrease the viability
(Figure 4), suggesting autophagy might be the predomin-
ant mechanism after radiation rather than apoptosis.
Moreover, the complex interrelationship between
apoptosis and autophagy has been reported to be
affected by various biochemical processes via different
pathways [38-40], and growing number of studies sug-
gested the presence of crosstalk between autophagy and
apoptosis; (a) Autophagy may be indispensable for apop-
tosis occurrence and lead to cell death; (b) Autophagy
may antagonize apoptosis and make cells survive from
stimuli; (c) Apoptosis and autophagy may occur inde-
pendent of each other, there might be molecular switch
between them, both autophagy and apoptosis determine
the final fate of cells [41]. In this study ZVAD inhibit
apoptosis and concomitantly inhibited autophagy in both
cell line (Figure 5). Wu YT also got the same results and
found ZVAD could inhibit lysosomal enzyme cathepsin
B activity, and subsequently blocked autophagosome
maturation [42]. Interestingly, 3MA play a different ef-
fect on apopotosis in SKOV3 and SKVCR, e.g., 3MA in-
hibit apoptosis in SKOV3, and promote apoptosis in
SKVCR (Figure 5), together with inhibition of autophagy.
Due to direct inhibition of autophagy and apoptosis ac-
tivity by 3MA in SKOV3 cells, the pro-survival role of
autophagy together with the death outcome of apoptosis
attenuated the radiation-induced cell death to a signifi-
cant extent. While in SKVCR cells autophagy inhibition
triggered the up-regulation of apoptosis, suggesting
there might be a molecular switch between autophagy
and apoptosis in SKVCR cells, autophagy coordinated
with apoptosis to improve the radiosensitivity. In recent
years, more and more researches suggested that the
apoptosis and autophagy could be mutually antagonistic
or promoted in some scenario. The same induction fac-
tors can play a positive or negative role for the two kinds
of programmed cell death in different cells. For example,
Figure 6 (See legend on next page.)
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Figure 6 Autophagy inhibition attenuates IR-induced cell cycle arrest. (A) Flow cytometry was used to quantitative the cell cycle rate with
or without autophagy inhibitor, 3MA (5 mM), with or without indicated IR regimens at 24 h in SKVO3; SKOV3 cell population (%) in G1 phase (B),
S phase (C), G2 phase (D) were quantified. (E) Flow cytometry was use to quantitative the cell cycle rate with or without autophagy inhibitor,
3MA (5mM, with or without indicated IR regimens at 24 h in SKVCR. SKVCR cells were treated with IR or a combination of both (5 mM 3MA
followed by IR) for 24 h, SKVCR cell population (%) in G1 phase (F), S phase (G), G2 phase (H) were quantified. All data are representative of three
independent experiments and are shown as the mean ± SD. *P<0.05. vs untreated 3MA group.
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or inhibit apoptosis [43]. Which has been confirmed by
our data.
In general, it has been found that cell radiosensitivity
is directly proportional to the rate of cell division and in-
versely proportional to the degree of cell differentiation,
this is described by the law of Bergonie and Tribondeau,
formulated in 1906 [44]. With regard to relation be-
tween cell cycle and radiosensitivity, cells are least sensi-
tive when arrested in the S phase, then the G1 and G2
phase, the most sensitive one is the M phase of the cell
cycle. Ge JN et al. showed that starvation could not only
induce autophagy in tumor cells, but also caused tumor
cell cycle arrest [45]. Here, we showed that G2 / M phase
arrest was induced by radiation in SKOV3 cell and
SKVCR cell lines. The accumulation of G2 / M phase
cells was more significant in SKOV3 cells. These results
go along with many previous reports, for example,
Rui Wei et al. found radiation with 6 MV X-rays caused
G2/M arrest A549 and A549/DDP cells [29]. In our
study, 3MA could inhibit autophagy and attenuate the
radiation-induced S phase delay in SKVCR, suggesting
3MA regulate cell cycle by redistribution, adjusting
radiation-induced cell cycle redistribution. Therefore,
3MA synergized the killing effects of radiation by de-
creasing the proportion of cells in S phase which has
been thought the least sensitive phase to radiation, con-
sequently increased the radiosensitivity of SKVCR cells.
Conclusions
The 3MA can not only inhibit autophagy, but also in-
hibit the radiation- induced S phase delay and increase
apoptosis in SKVCR cells, ultimately leading to the in-
crease of cell death. These data illustrated that inhibition
of autophagy may enhance the cell-killing effect of
radiotherapy in multidrug-resistant human ovarian can-
cer cells, which may represent a novel approach to in-
crease the efficacy of radiotherapy as an anticancer
modality.
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